|
Sign In to gain access to subscriptions and/or personal tools.
|
A Grading Scheme for the Assessment of Proliferative Lesions of the Mouse Prostate in the TRAMP Model
Andrew Suttie
Integrated Laboratory Systems, Research Triangle Park, North Carolina 27709, asuttie{at}ils-inc.com
Abraham Nyska
Laboratory of Experimental Pathology
Joseph K. Haseman
Biostatistics Branch, National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, North Carolina 27709
Glenda J. Moser
Integrated Laboratory Systems, Research Triangle Park, North Carolina 27709
Theleria R. Hackett
Integrated Laboratory Systems, Research Triangle Park, North Carolina 27709
Thomas L. Goldsworthy
Integrated Laboratory Systems, Research Triangle Park, North Carolina 27709
To improve the precision and consistency of experimental results, we have developed a scoring system for proliferative epithelial lesions in the mouse prostate based on histological growth patterns observed in individual lobes. Severity of proliferative lesions was divided into 6 categories; the grade of the most advanced lesion was identified for each lobe and its distribution estimated semiquantitatively. A numerical score combining grade and distribution of the most advanced lesion in each lobe was assigned and termed the "distribution-adjusted lesion grade"; the mean of these scores was calculated for each treatment group. Using this grading scheme, we assessed lesion development in ad libitum-fed and 20%-diet-restricted groups of TRAMP (Transgenic Adenocarcinoma of Mouse Prostate) mice that were started on study at 7 weeks of age and sacrificed when 11 and 20 weeks old. The anterior, dorsal, lateral, and ventral prostate lobes showed clear reductions in lesion severity in diet-restricted TRAMPs at 11 and 20 weeks. This method for scoring the epithelial pathology of the prostate in the TRAMP model with minimal to severe proliferative lesions utilizes the natural history of lesion development for assessing the effects of chemical and dietary interventions.
Key Words: Grading • quantitation • histopathology • mouse prostatic cancer • TRAMP.
References
- Cotran RS, Kumar V., Collins T. (1999). RobbinsPathologicBasis of Disease. WB Saunders Co, Philadelphia.
- Demark-Wahnefried W., Price DT, Polascik TJ, Robertson CN, Anderson EE, Paulson DF, Walther PJ, Gannon M., Vollmer RT (2001). Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: Exploring the effects on hormonal levels, prostatespecific antigen, and histopathologic features. Urology 58: 47—52.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Eng MH, Charles LG, Ross BD, Chrisp CE, Pienta KJ, Greenberg NM, Hsu CX, Sanda MG (1999). Early castration reduces prostatic carcinogenesis in trangenic mice. Urology 54: 1112—1119.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gingrich JR, Barrios RJ, Foster RJ, Greenberg NM (1999). Pathologic progression of autochthonous prostate cancer in the TRAMP model. Prostate Cancer and Prostatic Diseases 2: 70—75.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gingrich JR, Barrios RJ, Kattan MW, Nahm HS, Finegold MJ, Greenberg NM (1997). Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res 57: 4687—4691.[Abstract/Free Full Text]
- Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R., Rosen JM, Greenberg NM (1996). Metastatic prostate cancer in a transgenic mouse. Cancer Res 56: 4096—4102.[Abstract/Free Full Text]
- Greenberg NM, De Mayo F., Finegold MJ, Medina D., Tilley WD, Aspinal JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM (1995). Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92: 3439—3443.[Abstract/Free Full Text]
- Gupta S., Ahmad N., Marengo SR, MacLennan GT, Greenberg NM, Mukhtar H. (2000). Chemoprevention of prostate carcinogenesis by difluoromethylornithine in TRAMP Mice. Cancer Res 60: 5125—5133.[Abstract/Free Full Text]
- Gupta S., Hastak K., Ahmad N., Lewin JS, Mukhtar H. (2001). Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 98: 10350—10355.[Abstract/Free Full Text]
- Keenan KP, Laroque P., Ballam GC, Soper KA, Dixit R., Mattson BA, Adams SP, Coleman JB (1996). The effects of diet, ad libitum overfeeding, andmoderate dietary restriction on the rodent bioassay: The uncontrolled variable in safety assessment. Toxicol Pathol 24: 757—768.[Abstract/Free Full Text]
- Masumori N., Thomas TZ, Chaurand P., Case T., Paul M., Kasper S., Caprioli RM, Tsukamoto T., Shappell SB, Matusik RJ (2001). A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Cancer Res 61: 2239— 2249.[Abstract/Free Full Text]
- Nyska A., Suttie A., Lomnitski L., Bakshi S., Grossman S., Bergman M., Ben Shaul V., Crockett P., Haseman JK, Moser G., Goldsworthy T., Maronpot RR (2002). Slowing tumorigenic progression in TRAMP mice and prostatic carcinoma cell lines using natural antioxidant from spinach, NAO—A comparative study of three antioxidants. Toxicol Pathol, 31: 39—51.[Web of Science]
- Shibata MA, Ward JM, Devor DE, Liu ML, Green JE (1996). Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: Histopathological and molecular biological alterations. Cancer Res 56: 4894—4903.[Abstract/Free Full Text]
- Suwa T., Nyska A., Haseman JK, Mahler JF, Maronpot RR (2002). Spontaneous lesions in control B6C3F1 mice and recommended sectioning of male accessory sex organs. Toxicol Pathol 30: 228—234.[Abstract/Free Full Text]
- US Department of Health and Human Services (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington DC.
- Wechter WJ, Leipold DD, Murray ED Jnr., Quiggle D., McCracken JD, Barrios RS, Greenberg NM (2000). E-7869 (R-Flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse. Cancer Res 60: 2203— 2208.[Abstract/Free Full Text]
- Weindruch R. (1996). The retardation of aging by caloric restriction: Studies in rodents and primates. Toxicol Pathol 24: 742—745.[Abstract/Free Full Text]
- Whiteley LO, Anver MR, Botts S., Jokinen MP (1996). Proliferative lesions ofthe intestine, salivary glands, oral cavity, and esophagus in rats. In: Guides for Toxicologic Pathology. STP/ARP/AFIP, Washington, DC.
Toxicologic Pathology, Vol. 31, No. 1,
31-38 (2003)
DOI: 10.1080/01926230390173842
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
A. M. Sargeant, R. C. Rengel, S. K. Kulp, R. D. Klein, S. K. Clinton, Y.-C. Wang, and C.-S. Chen
OSU-HDAC42, a Histone Deacetylase Inhibitor, Blocks Prostate Tumor Progression in the Transgenic Adenocarcinoma of the Mouse Prostate Model
Cancer Res.,
May 15, 2008;
68(10):
3999 - 4009.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Sargeant, R. D. Klein, R. C. Rengel, S. K. Clinton, S. K. Kulp, Y. Kashida, M. Yamaguchi, X. Wang, and C.-S. Chen
Chemopreventive and Bioenergetic Signaling Effects of PDK1/Akt Pathway Inhibition in a Transgenic Mouse Model of Prostate Cancer
Toxicol Pathol,
June 1, 2007;
35(4):
549 - 561.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. W. Suttie, G. E. Dinse, A. Nyska, G. J. Moser, T. L. Goldsworthy, and R. R. Maronpot
An Investigation of the Effects of Late-Onset Dietary Restriction on Prostate Cancer Development in the TRAMP Mouse
Toxicol Pathol,
April 1, 2005;
33(3):
386 - 397.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C.L. Schuh
Trials, Tribulations, and Trends in Tumor Modeling in Mice
Toxicol Pathol,
January 1, 2004;
32(1_suppl):
53 - 66.
[Abstract]
[PDF]
|
|
|
|
|
